01 Oct 2019

Getting the Gold!

BioPlus earned not just one, but two!, accolades on September 26th at the 2019 Golden 100 Awards hosted annually by the Orlando Business Journal.

First up, BioPlus was recognized with the Ultimate Newcomer Award 2019. Next, BioPlus earned a very impressive 4th place in the Golden 100, meaning we are one of the 100 most profitable private companies in the region. Our 4th place was based on revenue, relative to the other top Central Florida businesses.

The Golden 100 celebrates Central Florida’s top 100 privately-held companies in regards to business excellence and general contributions to the Central Florida business community.

30 Aug 2019

BioPlus Specialty Pharmacy Ensures Continuity of Care Ahead of Dorian

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, passes along the following update about pharmacy operations in advance of the coming storm.


We know you are closely watching the weather reports on Hurricane Dorian and the potential impact to Florida, Georgia, and the east coast. This short message is to let you know what BioPlus has done and is doing to protect the medicine of your patients during this difficult time.

Earlier this week, we used parcel management technology and weather tracking models to analyze the geographical areas that might be affected by the hurricane.

We were able to identify which patients and medication packages might be at risk for disruption based on zip codes. We contacted those patients to arrange early shipments and ensure that they had enough medication on hand to pass the storm.

Our emergency preparedness team is on high alert and ready to work through any potential post-storm scenarios. Our systems will remain functional and we will have a pharmacist on call at all times.

We have taken many steps to ensure your patients and their medication shipments are protected and will continue to move through our system.

Please note our corporate office will be closed on Tuesday, September 3rd. We will reopen and return to full operations as soon as employee safety can be ensured.

About BioPlus Specialty Pharmacy
BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 30 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, rheumatology, dermatology, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: https://bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

30 Aug 2019

BioPlus Specialty Pharmacy in Semi-Exclusive Relationship to Dispense Vyleesi™ (Bremelanotide Injection)

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, announces that it will be one of only two specialty pharmacies to dispense the newly approved medication Vyleesi™ (bremelanotide injection). Vyleesi, from AMAG Pharmaceuticals, Inc., earned approval from the U.S. Food and Drug Administration (FDA) on June 21, 2019 for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women.

Vyleesi is the first as-needed treatment option for this patient population that can be self-administered in anticipation of sexual activity. HSDD is characterized by low sexual desire that causes distress or interpersonal difficulty and is not due to a co-existing medical or psychiatric condition, problems with the relationship, or the effects of a medication or other drug substance. HSDD affects approximately 1 in 10 premenopausal women. Vyleesi is self-administered with an autoinjector at least 45 minutes before anticipated sexual activity. Patients should not administer more than one dose within 24 hours or 8 doses per month.

“BioPlus is ready to dispense Vyleesi to eligible to patients,” shares David DuRoss, Senior Vice President of Trade for BioPlus. “With our extensive history and expertise with specialty pharmaceuticals, we’re proud that BioPlus was selected as a specialty pharmacy for this new medication. Our pharmacists are available 24/7, putting us in a unique position to guide patients through starting treatment,” he adds.

The FDA approval of this medication was based on two identical pivotal trials of approximately 1,200 women demonstrating that Vyleesi improved desire and reduced distress related to HSDD as measured by validated patient-reported outcome instruments. At the end of the core six-month studies, women were given the option to continue in an open-label extension study for an additional year. Approximately 80% of the women who completed the six-month studies chose to volunteer for the open label extension in which all the women received Vyleesi. In the pivotal trials, the most common adverse events were nausea, flushing, injection site reactions, headache, and vomiting. The majority of these events were reported to be transient and mild-to-moderate in intensity. Vyleesi also caused small, transient increases in blood pressure and decreases in heart rate, as well as darkening of the skin in some women. Women who are pregnant, or have uncontrolled hypertension, known heart disease or are taking oral naltrexone-containing products intended to treat opioid or alcohol addiction should not use this medication. Women who can become pregnant should use effective birth control during treatment with Vyleesi.

About Vyleesi™ (bremelanotide injection)

Vyleesi is approved for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD). The prefilled Vyleesi autoinjector is self-administered into a woman’s abdomen or thigh at least 45 minutes before anticipated sexual activity and can be taken at any time of day. Vyleesi is thought to possess a novel mechanism of action. While the exact mechanism of action is unknown, Vyleesi is believed to bind to melanocortin receptors in the central nervous system.

For Full Prescribing Information please visit: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=9146ae05-918b-483e-b86d-933485ce36eb&audience=consumer

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 30 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, rheumatology, dermatology, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: https://bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

27 Feb 2019

BioPlus Specialty Pharmacy Earns #1 Independent Specialty Pharmacy Ranking in Physician Satisfaction Survey

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, proudly announces a #1 ranking in oncology and top scores overall in the recent Specialty Pharmacy Physician Office Staff Satisfaction Survey conducted by Zitter Health Insights. The #1 ranking of BioPlus in oncology is related to meeting the top concern of office staff when it comes to getting their patients started on therapy quickly.

“I am proud to see this survey showing BioPlus as the leader in the oncology space, with a particular callout from office staff that we meet the need for quick therapy starts for patients. We also earned top marks for our customer service, as well as scoring the highest rating for supporting the prior authorization process,” notes Stephen Vogt, Pharm.D., President and CEO of BioPlus. “Providing best-in-class care to our patients can only happen when we partner and communicate with prescribers, which is what this survey reveals,” he adds.

This survey found that office staff highly value the fast prior authorization process at BioPlus. Office staff also took appreciative note of BioPlus’ procedures in determining co-pay coverage and processing prior authorizations for medical offices, as well as complimenting BioPlus on fast starts.

The quick prior authorizations at BioPlus are traced back to BioPlus’ 2-Hour Patient Acceptance Guarantee. This guarantee means that BioPlus starts and finishes the prior authorization process in a timely fashion, which is generally achieved on that same day. This quick turnaround, based on these survey results, is clearly appreciated by physician offices.

BioPlus held the highest ranking for customer service in the oncology space in this survey and is primarily recommended by oncology staff because of superior customer service when compared with other pharmacies.

The Specialty Pharmacy Physician Office Staff Satisfaction Survey conducted by Zitter Health Insights covered the second half of 2016 (10/24 – 12/5 2016) and was based on 2,201 physician office personnel from physician offices nationwide which encompassed 14 medical specialties.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 27 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for hepatitis C, cancer, multiple sclerosis, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: https://bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

19 Sep 2018

BioPlus Specialty Pharmacy Announces David DuRoss as Senior Vice President of Trade

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, is pleased to announce that David DuRoss is joining the company in the newly created position of Senior Vice President of Trade.

“The creation of this new position – but more importantly finding the right person for this job – will support ongoing and future growth at our specialty pharmacy,” shares Stephen Vogt, Pharm.D., CEO of BioPlus. “David is that right person and we’re fortunate to have him on our team.”

DuRoss comes to BioPlus with 24 years of experience in both the wholesale and specialty pharmacy industries. This prior expertise will dovetail with DuRoss’ new role as he supports BioPlus internally, as well as serving as a leader in sourcing, purchasing, and contracting pharmaceuticals. In addition, he will assist BioPlus’ Payer and Sales teams in working together on new business opportunities.

“I am thrilled to be joining such a well-respected specialty pharmacy as BioPlus, with its patient-centric focus,” says DuRoss, “and I am looking forward to helping expand our market penetration.”

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 29 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, multiple sclerosis, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: https://bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

18 Sep 2018

BioPlus Specialty Pharmacy Announces New President: Mark Montgomery

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, announces today that Mark Montgomery has joined the company in the position of President. Stephen Vogt, Pharm.D., who previously held the dual position of both CEO and President, will continue in his role as CEO.

“Adding Mark as the new President of BioPlus comes at an exciting time for BioPlus as our company has been experiencing stellar growth and expansion within the specialty pharmacy field,” shares Dr. Vogt. “With his proven leadership in the industry, I’m confident that he’ll be instrumental in bringing our dynamic and growing company to yet another level in terms of our development and implementation of growth strategies at BioPlus.”

Montgomery brings 25 years of specialty pharmacy experience to BioPlus, as evidenced by earning a spot on Specialty Pharmacy Times’ Top 30 Influential Persons in Specialty Pharmacy in 2011 and being named a Healthcare Entrepreneur of the Year in 2012 by Ernst & Young. “I have admired BioPlus for their patient-centric care and as a leading independent national specialty platform for the industry. I look forward to working with all of the great professionals BioPlus already has onboard,” says Montgomery.

Previously Montgomery built Axium Healthcare Pharmacy into a leading national specialty pharmacy and shepherded its successful sale in 2012 to the Kroger organization. He is also a founder and past board member of the National Association of Specialty Pharmacies.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 29 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, multiple sclerosis, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: https://bioplusrx.com or
Contact: info(at)bioplusrx(dot)com
Phone: 1-888-292-0744

04 Sep 2018

BioPlus Specialty Pharmacy Earns Spot on Orlando Sentinel’s 2018 ‘Top 100 Companies’

BioPlus Specialty Pharmacy (BioPlus), one of the nation’s leading innovative specialty pharmacies, proudly announces that our company earned placement on the Orlando Sentinel ‘Top 100 Companies’ list for 2018. This honor illustrates that BioPlus is one of the best places to work in Central Florida.

Over the past 29 years, BioPlus has brought an ethical approach to the work of a specialty pharmacy while specializing in oncology, hepatitis C, Crohn’s disease, dermatology, and multiple sclerosis, along with other conditions. BioPlus is known for our 2-Hour Patient Acceptance Guarantee: A promise that BioPlus will conduct a full benefits investigation and inform physicians within two hours whether they will be able to service a patient.

“Just as we are ‘all in’ for our patients, we do the same for our employees by offering a
diverse and enriching work environment, with many benefits and perks – from a strong retirement plan, employee quarterly bonuses, and paid time off to monthly employee recognition, award opportunities, socializing activities, such as food trucks at lunch time, holiday contests, charity projects, and career development support. In every way, BioPlus stands with their employees and it’s satisfying to see this recognized by being listed as a top workplace for employees from the Orlando Sentinel,” shares Bonnie Walsh, Director of Human Resources at BioPlus.

The Orlando Sentinel announced 2018’s Top 100 Companies at a luncheon August 10, 2018 in Orlando. BioPlus Specialty Pharmacy ranked as #19 in the mid-size division of this award.

“It’s exciting to see our list of accolades continue to expand, with this latest honor adding to our other recent recognitions, including spots on Inc. Magazine Top 5,000 award, numerous awards from Zitter Health Insights (such as being #1 in patient satisfaction in oncology and hepatitis C of independent specialty pharmacies in their latest survey), and receiving a Distinction in Oncology from the Accreditation Commission for Health Care,” Walsh adds.

About BioPlus Specialty Pharmacy

BioPlus Specialty Pharmacy is a leading independent, national specialty pharmacy and the first and only specialty pharmacy to offer a two-hour turnaround from referral to patient acceptance. Our company celebrates 29 years of innovative excellence in specialty pharmacy, working closely with payers and the pharmaceutical industry, as well as with prescribers to get prompt treatment for patients, and directly supporting our patients nationwide to achieve optimal health outcomes. We provide a complete range of specialty services, including for cancer, multiple sclerosis, hepatitis C, and other complex, chronic conditions. BioPlus, a privately-held, pharmacist-owned company based in Altamonte Springs, Florida, is accredited by URAC, VIPPS, and ACHC with a Distinction in Oncology.

For information: http://www.bioplusrx.com or
Contact: info(at)bioplusrx.com
Phone: 1-888-292-0744

###

04 Sep 2018

Eat to Calm Psoriasis

Most people with psoriasis will have some degree of symptoms for life. But this doesn’t mean that improvement can’t happen. Medications help keep this skin disease under control and combining medication with certain dietary choices can also have a positive effect on both psoriasis and psoriatic arthritis (which is a joint condition related to the skin disease).

The Medical Board of the National Psoriasis Foundation recently reviewed the current body of scientific research so they could share the latest understandings about how diet affects psoriasis and psoriatic arthritis. Their review included 55 studies – which covered more than 77,000 people both with and without psoriasis.

The biggest take-away from this National Psoriasis Foundation project relates to overweight or obese patients with psoriasis. It may not be the most popular news to hear, but the evidence shows that a low-calorie diet with the goal of losing weight leads to significant improvements in the severity of psoriasis symptoms, as well as (obviously) weight loss and an improved “dermatology quality of life.” Losing weight improves both skin and joint symptoms of psoriasis, which is why this dietary change earned the Medical Board’s strongest recommendation.

People with psoriasis are known to have a higher risk of also developing celiac disease, which is why gluten-free diets tend to be popular with psoriasis sufferers. According to this Medical Board, gluten-free diets have shown some benefit, but only in patients who test positive (based on a blood test) for gluten sensitivity. In these situations, a three-month trial of going gluten-free can make sense.

In terms of dietary supplements, the strongest evidence emerged for vitamin D supplements, but this recommendation was geared specifically to overweight/obese patients with psoriatic arthritis.

One final thing that’s important to keep in mind: all of these dietary changes are recommended to be done in combination with a medication plan of care – not in place of one.

Sources

Ford AR, Siegel M, Bagel J, et al. Dietary recommendations for adults with psoriasis or psoriatic arthritis from the medical board of the National Psoriasis Foundation: A systemic review. JAMA Dermatol 2018;154(8):934-50.

04 Sep 2018

Rheumatoid Arthritis Vs. The Scale

Carrying around extra pounds can increase the risk of developing rheumatoid arthritis – but the relationship between weight and this autoimmune disease actually isn’t as cut and dried as it first appears.

First, it should be acknowledged that as body fat and waist circumference goes up, so does the chance of rheumatoid arthritis. Upwards of two-thirds of people with rheumatoid arthritis are either overweight or obese. There is no getting around the fact that extra pounds are risky when it comes to rheumatoid arthritis development.

This obesity-RA relationship comes with a gender difference; specifically, the link shows stronger in women than in men. So for a woman at risk for rheumatoid arthritis down the road (due to family history, age, and/or smoking), losing weight can reduce the risk of disease development. Overall in the United States, the rates of obesity and rheumatoid arthritis continue to rise – which is certainly a public health concern.

Obesity creates several problems in rheumatoid arthritis:

  • Greater weight means more stress on disease-damaged joints.
  • Being overweight tends to make RA symptoms worse.
  • Medication might not work as well, particularly biologics and some DMARDs.

But this weight issue gets a little more interesting in people who already have rheumatoid arthritis. Being overweight helps in one way: higher weight links to a lower risk of mortality from rheumatoid arthritis. In other words, normal weight people die earlier from RA than those who carry extra pounds. This is known as the obesity paradox, in which being overweight correlates to living longer. Body mass index (BMI) of greater than 30 is the threshold where this benefit emerges in those with rheumatoid arthritis.

So what should patients take away from this? Maintaining a healthy BMI reduces the risk of rheumatoid arthritis. In addition there are benefits for achieving healthy weight in those with active RA, since medications tend to be more effective and the additional risk of osteoarthritis is lessened. Of course there are other health benefits of healthy BMI, such as heart health. Overall, the benefits of achieving a normal BMI continue to outweigh any negatives.

Sources

Linauskas A, Overvad K, Symmons D, et al. Body fat percentage, waist circumference and obesity as risk factors for rheumatoid arthritis – A Danish cohort study. Arth Care Res 2018 July 5 doi: 10.1002/acr.23694.

Dar L, Tiosano S, Watad A, et al. Are obesity and rheumatoid arthritis interrelated? Int J Clin Pract 2018;72(1). doi: 10.1111/ijcp.13045.

04 Sep 2018

The Latest Word in HCV Treatment

New guidelines for treating hepatitis C infections came out from the World Health Organization. These replace and update WHO’s 2016 recommendations. Certainly a lot has changed in just the past three years – all of it comes as great news for anyone carrying the hepatitis C virus (HCV).

The key take-away from these comprehensive new guidelines (all 108 pages of them!) center on one game-changing strong recommendation:

  • Hepatitis C treatment should be offered to all people age 12+ (except pregnant women) with chronic hepatitis C infection, regardless of their disease stage.

In other words, treatment should not be delayed until the disease causes more serious health consequences. Treat HCV early and treat everyone.

A second big change to HCV recommendations relates to selecting a treatment:

  • Direct-acting antivirals, which work on all six major genotypes of HCV, should be used.

Since these types of medications effectively treat all types of HCV, it is no longer necessary to spend time and money on genotyping the infection (which previously was used to select the best treatment). The new course of action sums up as: get tested and get treated with one of the new direct-acting antivirals that work on all major forms of HCV.

WHO set a goal to eliminate viral hepatitis by the year 2030. It’s a tall order, but one that would save millions of lives. To achieve this goal, 90% of people who are infected need to get diagnosed with this disease (you can’t treat it if you don’t know you have it!) and 80% of people with a diagnosis need to be treated. So let’s get to it!

Source

World Health Organization. Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection. July 2018. http://apps.who.int/iris/bitstream/handle/10665/273174/9789241550345-eng.pdf?ua=1